CD8A and neoplasm: As shown in Figure 2D, the addition of tumor-infiltrated CD8+ T cells at 5-fold excess of the hPD-L1 MC38 cell number, RGE treatment effectively inhibited the amount of surviving hPD-L1 MC38 cells.